Biotronik Can't Seek $100M From J&J Over Stents: Judge

Law360, New York (October 24, 2011, 7:34 PM EDT) -- German drugmaker Biotronik AG can't seek $100 million in lost profits in a suit claiming a Johnson & Johnson unit breached a supply contract by issuing a bogus CoStar stent recall, a New York judge ruled in an order filed Friday.

Judge Bernard J. Fried rejected J&J unit Conor Medsystems Inc.'s summary judgment bid, but hobbled Biotronik's case by ruling that it couldn't go after Conor for lost profits — the only damages it was seeking.

Conor pulled its CoStar stents off the market in 2007...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.